Pantoprazole suppresses carcinogenesis and growth of hepatocellular carcinoma by inhibiting glycolysis and Na + /H + exchange
Drug Development Research · 2024
DOI: 10.1002/ddr.22198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Hai Jin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Glycolysis, Liver Neoplasms, Pantoprazole. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is one of the deadliest cancers. The prevention and therapy for this deadly disease remain a global medical challenge. In this study, we investigated the effect of pantoprazole (PPZ) on the carcinogenesis and growth of HCC. Both diethylnitrosamine (DEN) plus CCl4‐induced and DEN plus high fat diet (HFD)‐induced HCC models in mice were established. Cytokines and cell proliferation‐associated gene in the liver tissues of mice and HCC cells were analyzed. Cellular glycolysis and Na + /H + exchange activity were measured. The preventive administration of pantoprazole (PPZ) at a clinically relevant low dose markedly suppressed HCC carcinogenesis in both DEN plus CCl4‐induced and HFD‐induced murine HCC models, whereas the therapeutic administration of PPZ at the dose suppressed the growth of HCC. In the liver tissues of PPZ‐treated mice, inflammatory cytokines, IL1, CXCL1, CXCL5, CXCL9, CXCL10, CCL2, CCL5, CCL6, CCL7, CCL20, and CCL22, were reduced. The administration of CXCL1, CXCL5, CCL2, or CCL20 all reversed PPZ‐suppressed DEN plus CCL4‐induced HCC carcinogenesis in mice. PPZ inhibited the expressions of CCNA2, CCNB2, CCNE2, CDC25C, CDCA5, CDK1, CDK2, TOP2A, TTK, AURKA, and BIRC5 in HCC cells. Further results showed that PPZ reduced the production of these inflammatory cytokines and the expression of these cell proliferation‐associated genes through the inhibition of glycolysis and Na + /H + exchange. In conclusion, PPZ suppresses the carcinogenesis and growth of HCC, which is related to inhibiting the production of inflammatory cytokines and the expression of cell proliferation‐associated genes in the liver through the inhibition of glycolysis and Na + /H + exchange.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
ORCID-Profile: Biguang Tuo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jin, H., Wen, G., Zhu, J., Liu, J., Li, J., Yao, S., Zhao, Z., Dong, Z., Zhang, X., An, J., Liu, X., & Tuo, B. (2024). Pantoprazole suppresses carcinogenesis and growth of hepatocellular carcinoma by inhibiting glycolysis and Na + /H + exchange. Drug Development Research. https://doi.org/10.1002/ddr.22198
Vancouver
Jin H, Wen G, Zhu J, Liu J, Li J, Yao S, et al. Pantoprazole suppresses carcinogenesis and growth of hepatocellular carcinoma by inhibiting glycolysis and Na + /H + exchange. Drug Development Research. 2024. doi:10.1002/ddr.22198
BibTeX
@article{Jin2024,
author = {Jin, Hai and Wen, Guorong and Zhu, Jiaxing and Liu, Jielong and Li, Jingguo and Yao, Shun and Zhao, Zhenglan and Dong, Zhiqi and Zhang, Xue and An, Jiaxing and Liu, Xuemei and Tuo, Biguang},
title = {Pantoprazole suppresses carcinogenesis and growth of hepatocellular carcinoma by inhibiting glycolysis and Na + /H + exchange},
journal = {Drug Development Research},
year = {2024},
doi = {10.1002/ddr.22198}
}
EUVIMED